Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

Description

“Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on benign prostatic hyperplasia (bph) treatment devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for benign prostatic hyperplasia (bph) treatment devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The benign prostatic hyperplasia (bph) treatment devices and equipment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product: Resectoscopes; Radiofrequency Ablation Device; Urology Lasers; Prostatic Stents; Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA); Transurethral Resection Of Prostate (TURP); Transurethral Incision Of Prostate (TUIP); Transurethral Microwave Thermotherapy (TUMT); Laser Surgery; Other Procedure Types
3) By End-User: Hospitals; Ambulatory Surgical Centres (ASC); Clinics; Home
Companies Mentioned: Karl Storz; Lumenis Ltd.; Olympus Corporation; Urologix LLC; Boston scientific Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Benign Prostatic Hyperplasia (BPH), also known as benign prostatic hypertrophy, signifies the enlargement of the prostate gland leading to urethral blockage, hindering the normal urine flow from the bladder.

The primary offerings in the market for devices and equipment aimed at treating Benign Prostatic Hyperplasia (BPH) include resectoscopes, radiofrequency ablation devices, urology lasers, prostatic stents, and implants. Resectoscopes serve as endoscopic tools employed in surgeries involving the uterus, prostate, bladder, or urethra, enabling the extraction of tissue for biopsy, removal of growths, or ablation of diseased or damaged tissue. Various procedures conducted encompass transurethral needle ablation (TUNA), transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), transurethral microwave thermotherapy (TUMT), laser surgery, among others. The diverse user segments involved in utilizing these products include hospitals, ambulatory surgical centers (ASCs), clinics, and home-based applications.

The benign prostatic hyperplasia (BPH) treatment market research report is one of a series of new reports from The Business Research Company that provides benign prostatic hyperplasia (BPH) treatment market statistics, including benign prostatic hyperplasia (BPH) treatment industry global market size, regional shares, competitors with a benign prostatic hyperplasia (BPH) treatment market share, detailed benign prostatic hyperplasia (BPH) treatment market segments, market trends and opportunities, and any further data you may need to thrive in the benign prostatic hyperplasia (BPH) treatment industry. This benign prostatic hyperplasia (BPH) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The benign prostatic hyperplasia (bph) treatment devices and equipment market size has grown strongly in recent years. It will grow from $1.58 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth witnessed in the past period can be attributed to several factors, including an aging population, increased awareness and diagnoses, expanded healthcare access, and the development of personalized treatment approaches.

The benign prostatic hyperplasia (bph) treatment devices and equipment market size is expected to see strong growth in the next few years. It will grow to $2.14 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. Anticipated growth in the upcoming period can be attributed to several factors such as the adoption of minimally invasive techniques, expanding markets in emerging economies, support from regulatory bodies, and the advancement of value-based healthcare models. Major trends expected during this period include the prominence of non-surgical and office-based procedures, the utilization of laser and radiofrequency technologies, the increased implementation of telemedicine and remote consultations, and a growing emphasis on patient education and engagement.

Benign Prostatic Hyperplasia (BPH), also known as Prostate Gland Enlargement (PGE), is characterized by uncomfortable urinary symptoms in patients. The increasing prevalence of BPH has led to a growing demand for BPH treatment devices and equipment. As the number of reported BPH cases continues to increase, the demand for these devices is expected to rise correspondingly. For instance, in 2021, over 14 million men in the United States exhibited symptoms of BPH, and globally, around 30 million men experienced BPH-related symptoms. This rise in BPH cases is anticipated to drive the demand for BPH treatment devices and equipment.

The anticipated rise in prostate cancer cases is set to fuel the expansion of the benign prostatic hyperplasia (BPH) market. With prostate cancer impacting a growing number of men, there is an increased need for medical attention among older males regarding prostate-related issues. This surge in cancer cases contributes to the identification and management of benign prostatic hyperplasia. According to the American Society of Clinical Oncology (ASCO), estimations in 2023 suggested about 288,300 men were affected by prostate cancer in the United States. The year 2022 witnessed 268,490 new cases and 34,500 deaths related to prostate cancer. This trajectory in prostate cancer cases is a significant driver behind the growth of the benign prostatic hyperplasia market.

The market for BPH devices and equipment encounters a significant restraint due to patient-experienced side effects following BPH procedures. For instance, common side effects of such surgeries include urinary incontinence, urination discomfort, and challenges in fully emptying the bladder. These experiences deter patients suffering from BPH from opting for surgical procedures (unless absolutely necessary), leading to reduced demand for such treatments. Consequently, this decreased demand affects the utilization of devices by key end-users such as hospitals, clinics, and ambulatory surgical centers.

Prostatic Artery Embolization (PAE) represents a cutting-edge advancement in the field of Benign Prostatic Hyperplasia (BPH) treatment devices and equipment. It offers a minimally invasive approach to alleviating urinary tract symptoms related to BPH. PAE employs state-of-the-art imaging technologies, including X-rays, to visualize and treat the tumor inside the body without the need for invasive surgery. This technique significantly reduces treatment complications associated with BPH. Notable industry leaders such as Boston Scientific, UNC Healthcare, and Spire Healthcare have made substantial investments in the development and advancement of PAE technologies, emphasizing the growing significance of this innovation in the BPH treatment market.

Major companies in the benign prostatic hyperplasia market are heavily invested in creating innovative solutions, such as the UroLift 2 System and UroLift ATC advanced tissue control system, aimed at delivering dependable services to the market. Specifically designed to address lower urinary tract symptoms related to benign prostatic hyperplasia (BPH), these systems are developed to offer enhanced treatment methodologies. For example, in May 2022, Teleflex Incorporated, a US-based medical device company, introduced the UroLift 2 System and UroLift ATC. The UroLift 2 System is a specialized delivery system crafted to access the prostatic urethra and implant permanent UroLift devices through the prostate's lobes. On the other hand, the UroLift ATC advanced tissue control system is a minimally invasive procedure created to manage symptoms stemming from an enlarged prostate. These innovations represent an evolutionary approach in treating benign prostatic hyperplasia (BPH), addressing the obstruction of the urethra by lifting and holding the enlarged prostate tissue.

In March 2021, Olympus Corporation, a Japan-based producer of optical and reprographic tools, completed the acquisition of Medi-Tate, strengthening its urology division and broadening its range of minimally invasive treatment offerings. The acquisition was strategically aimed at bolstering the company's portfolio of non-surgical solutions, enhancing men's healthcare, and improving overall quality of life. Medi-Tate, an Israel-based medical device firm, is focused on delivering effective, non-surgical treatments to elevate men's health and wellness.

Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International PLC, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic PLC, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the benign prostatic hyperplasia (BPH) treatment devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The benign prostatic hyperplasia (BPH) treatment devices and equipment market consist of sales of prostatic stents, catheter ablation devices, resectoscopes, radiofrequency ablation devices, urology lasers, and prostatic stents that are used to treat benign prostatic hyperplasia. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r8918

1. Executive Summary

2. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Characteristics

3. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends And Strategies

4. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Size and Growth

5.1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Segmentation

6.1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Resectoscopes
Radiofrequency Ablation Device
Urology Lasers
Prostatic Stents
Implants
6.2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Transurethral Needle Ablation (TUNA)
Transurethral Resection Of Prostate (TURP)
Transurethral Incision Of Prostate (TUIP)
Transurethral Microwave Thermotherapy (TUMT)
Laser Surgery
Other Procedure Types
6.3. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Ambulatory Surgical Centres (ASC)
Clinics
Home

7. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Regional And Country Analysis

7.1. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

8.1. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

9.1. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
9.2. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

10.1. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

11.1. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

12.1. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

13.1. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

14.1. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

15.1. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
15.2. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

16.1. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

17.1. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

18.5. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

19.9. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

20.13. Spain Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

21.1. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
21.2. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

22.1. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

23.1. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
23.2. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

24.1. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
24.2. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

25.1. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
25.2. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

26.1. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
26.2. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

27.1. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

28.1. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
28.2. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

29.1. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Overview
29.2. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Landscape And Company Profiles

30.1. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Landscape
30.2. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Company Profiles
- 30.2.1. Karl Storz
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Lumenis Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Olympus Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Urologix LLC
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Boston scientific Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Benchmarking

32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market

34. Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Future Outlook and Potential Analysis

34.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2028 - Countries Offering Most New Opportunities
34.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2028 - Segments Offering Most New Opportunities
34.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer